خانه › سرطان ریه غیرسلول کوچک › میسوری › Kansas City
آزمایش‌های بالینی سرطان ریه غیرسلول کوچک در Kansas City، MO
31 مطالعه برای سرطان ریه غیرسلول کوچک در مراکز Kansas City (در شعاع حدود ۳۰ مایل) در جستجوی شرکت‌کننده هستند. یک مطالعه را باز کنید تا شرایط شرکت و نحوه تماس با تیم پژوهشی را ببینید.
متن رسمی مطالعه (انگلیسی)
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
در حال جذب شرکت‌کنندهمرحله 3
- St. Lukes Hosp. of Kansas City /ID# 259940, Kansas City
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
در حال جذب شرکت‌کنندهمرحله 3
- Truman Medical Center ( Site 0126), Kansas City
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
در حال جذب شرکت‌کنندهمرحله 3
- Saint Luke's Hospital of Kansas City, Kansas City
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
در حال جذب شرکت‌کنندهمرحله 3
- University Health Truman Medical Center, Kansas City
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- St. Lukes Hospital of Kansas City, Kansas City
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
در حال جذب شرکت‌کنندهمرحله 3
- The University of Kansas Cancer Center, Westwood · 5 مایل فاصله
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
در حال جذب شرکت‌کنندهمرحله 2
- University of Kansas Cancer Center, Westwood · 5 مایل فاصله
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
در حال جذب شرکت‌کنندهمرحله 2
- Truman Medical Ctr West, Kansas City
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- Research Site, Westwood · 5 مایل فاصله
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
در حال جذب شرکت‌کنندهمرحله 3
- Saint Luke's Hospital of Kansas City, Kansas City
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
در حال جذب شرکت‌کنندهمرحله 3
- Research Site, Kansas City
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
در حال جذب شرکت‌کنندهمرحله 3
- Local Institution - 0498, Kansas City
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
در حال جذب شرکت‌کنندهمرحله 3
- Research Site, Kansas City
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
در حال جذب شرکت‌کنندهمرحله 3
- Clinical Study Site, Kansas City
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- University of Kansas, Westwood · 5 مایل فاصله
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
در حال جذب شرکت‌کنندهمرحله 2/3
- University of Kansas Medical Center /ID# 263196, Westwood · 5 مایل فاصله
A Phase 1/1b Study of IAM1363 in HER2 Cancers
در حال جذب شرکت‌کنندهمرحله 1
- Saint Luke's Cancer Institute, Kansas City
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
در حال جذب شرکت‌کنندهمرحله 3
- The University of Kansas Cancer Center - Westwood, Westwood · 5 مایل فاصله
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
در حال جذب شرکت‌کنندهمرحله 3
- University of Kansas Cancer Center - North, Kansas City
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
در حال جذب شرکت‌کنندهمرحله 1/2
- University of Kansas Medical Center (KUMC), Westwood · 5 مایل فاصله
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- MidAmerica Cancer Care, Kansas City
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
در حال جذب شرکت‌کنندهمرحله 1
- The University of Kansas Cancer Center - Westwood, Westwood · 5 مایل فاصله
- University of Kansas Cancer Center, Westwood · 5 مایل فاصله
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
در حال جذب شرکت‌کنندهمرحله 3
- University of Kansas Cancer Center - North, Kansas City
- University of Kansas Cancer Center, Westwood · 5 مایل فاصله
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
در حال جذب شرکت‌کنندهمرحله 1/2
- The University of Kansas Cancer Center, Westwood · 5 مایل فاصله
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
در حال جذب شرکت‌کنندهمرحله 2
- University Health Truman Medical Center, Kansas City
- University of Kansas Cancer Center - Briarcliff, Kansas City
- University of Kansas Cancer Center - North, Kansas City
- و 1 مورد دیگر
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
در حال جذب شرکت‌کنندهمرحله 3
- Research Site, Kansas City
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
در حال جذب شرکت‌کنندهمرحله 2
- University Health Truman Medical Center, Kansas City
- University of Kansas Cancer Center - Briarcliff, Kansas City
- University of Kansas Cancer Center - North, Kansas City
- و 1 مورد دیگر
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
در حال جذب شرکت‌کنندهمرحله 2/3
- University Health Truman Medical Center, Kansas City
- University of Kansas Cancer Center - Briarcliff, Kansas City
- Kansas City Veterans Affairs Medical Center, Kansas City
- و 2 مورد دیگر
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
در حال جذب شرکت‌کنندهمرحله 2
- University Health Truman Medical Center, Kansas City
- University of Kansas Cancer Center - Briarcliff, Kansas City
- University of Kansas Cancer Center - North, Kansas City
- و 1 مورد دیگر
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
در حال جذب شرکت‌کنندهمطالعه مشاهده‌ای
- University Health Truman Medical Center, Kansas City
- University of Kansas Cancer Center - Briarcliff, Kansas City
- University of Kansas Cancer Center - North, Kansas City
- و 1 مورد دیگر
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
در حال جذب شرکت‌کنندهمطالعه مشاهده‌ای
- Massive Bio SYNERGY-AI site, Kansas City
آزمایش‌های سرطان ریه غیرسلول کوچک در سایر شهرها
- Houston, TX145 مطالعه
- New York City, NY121 مطالعه
- Arlington, VA104 مطالعه
- Nashville, TN97 مطالعه
- Boston, MA90 مطالعه
- Los Angeles, CA87 مطالعه
- St. Louis, MO73 مطالعه
- Chicago, IL61 مطالعه
- Baltimore, MD60 مطالعه
- San Antonio, TX59 مطالعه
- Columbus, OH57 مطالعه
- Washington, DC55 مطالعه
سایر مطالعات در Kansas City
- سرطان پستان34 مطالعه
- نارسایی قلبی25 مطالعه
- سرطان (همه انواع)21 مطالعه
- سرطان ریه19 مطالعه
- سرطان کولورکتال16 مطالعه
- سرطان متاستاتیک15 مطالعه
- لوکمیه حاد میلویید15 مطالعه
- سرطان پروستات14 مطالعه
- سرطان تخمدان11 مطالعه
- چاقی11 مطالعه
- دیابت نوع ۲11 مطالعه
- بیماری قلبی-عروقی11 مطالعه
از ClinicalTrials.gov، داده‌ها در تاریخ 6 اکتبر 2026 دریافت شده است. هر مطالعه شرایط اختصاصی خود را دارد؛ تیم پژوهشی تصمیم می‌گیرد چه کسانی می‌توانند شرکت کنند.